Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 4 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 260INDUSTRY 44NETWORK 11OTHER_GOV 6UNKNOWN 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Lung 1Advanced Pancreatic Cancer 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Albumin-Bound Paclitaxel × Clear all
NCT03415802 2021-02-01

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

ChineseAMS

Phase 2 Completed
32 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

NCT01980810 2016-06-14

GC-A-003

ChineseAMS

Phase 2 Terminated
36 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01969955 2014-04-25

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

ChineseAMS

Phase 2 Unknown
50 enrolled

Squamous Cell Carcinoma of Lung

NCT01667211 2012-08-22

CSAPPPCC

ChineseAMS

Phase 2 Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡